Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nalbuphine.

W K Schmidt, S W Tam, G S Shotzberger

    Drug and Alcohol Dependence
    |February 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Nalbuphine is a potent analgesic with a favorable side effect and dependence profile. It acts as a kappa-agonist/mu-antagonist, effectively antagonizing respiratory depression from other opioids with limited abuse potential.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of periconceptional nutrition on the growth, behaviour and survival of the neonatal lamb.

    Animal reproduction science·2015
    Same author

    Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
    Same author

    Observation of entanglement-dependent two-particle holonomic phase.

    Physical review letters·2014
    Same author

    Analysis of solution residues by glow discharge mass spectrometry.

    Journal of the American Society for Mass Spectrometry·2013
    Same author

    Secular trends in kidney disease: is the decreased incidence of renal replacement therapy due to a decrease in chronic kidney disease incidence?

    Clinical nephrology·2008
    Same author

    Harnessing stakeholder perspectives to improve the care of osteoporosis after a fracture.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2008

    Area of Science:

    • Pharmacology
    • Pain Management
    • Addiction Medicine

    Background:

    • Nalbuphine is an agonist/antagonist analgesic.
    • Existing analgesics like pentazocine, butorphanol, and buprenorphine have varying side effect and dependence profiles.
    • Understanding nalbuphine's unique pharmacological profile is crucial for its clinical application.

    Purpose of the Study:

    • To characterize the pharmacological profile of nalbuphine.
    • To compare nalbuphine's efficacy and safety with other opioid analgesics.
    • To assess nalbuphine's potential for abuse and dependence.

    Main Methods:

    • Animal studies evaluating analgesic and antagonist activities.
    • Clinical studies assessing respiratory, behavioral, and autonomic effects.

    Related Experiment Videos

  • Studies on the interaction with the narcotic abstinence syndrome.
  • Abuse potential assessment in humans.

    • Main Results:

    • Nalbuphine exhibits potent analgesic activity with a high antagonist to analgesic ratio.
    • It effectively antagonizes opioid-induced respiratory depression while potentiating analgesia.
    • Nalbuphine shows minimal behavioral, autonomic, and psychotomimetic effects compared to other agents.
    • It does not suppress but exacerbates opioid withdrawal, indicating low abuse potential.
    • Limited gastrointestinal inhibition and cardiovascular effects were observed.

    Conclusions:

    • Nalbuphine is a kappa-agonist/mu-antagonist analgesic with a favorable safety and dependence profile.
    • Its unique properties make it a valuable option for pain management, particularly when opioid-induced respiratory depression is a concern.
    • Nalbuphine has a low potential for abuse and dependence within its therapeutic range.